West Pharmaceutical Services (WST) Treasury Shares (2009 - 2026)

West Pharmaceutical Services (WST) has reported Treasury Shares for 18 consecutive years, with $1.5 billion the latest figure, recorded in Q2 2026.

• Quarterly Treasury Shares rose 32.63% year-over-year to $1.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.5 billion (up 32.63% YoY) and the FY2025 annual result came in at $1.1 billion, up 5.21% from the prior year.
• Treasury Shares rose to $1.5 billion in Q2 2026 per WST's latest filing, from $1.4 billion in the prior quarter.
• Over the last five years, Treasury Shares for WST reached as high as $4.9 million in Q2 2026 and fell as low as $1.1 million in Q1 2023.
• A 5-year average of $2.5 million and a median of $2.5 million in 2024 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2024 — Treasury Shares jumped 123.51% — and 2025, when it advanced 5.21%.
• Year by year, Treasury Shares stood at $370.9 million in 2022, then surged by 71.91% to $637.6 million in 2023, then jumped by 65.79% to $1.1 billion in 2024, then advanced by 5.21% to $1.1 billion in 2025, then jumped by 35.97% to $1.5 billion in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $1.5 billion, $1.4 billion, and $1.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.